BioSmart Co.Ltd
BioSmart Co.,Ltd. manufactures and sells magnetic stripe (MS) cards in South Korea. The company's magnetic stripe cards include credit cards, smart cards, traffic cards, securities cards, etc. It also sells card equipment, such as traffic card issuing machinery, smart card issuing machinery, credit card issuing machinery, etc.; provides card issuing services comprising MS card and IC chip persona… Read more
BioSmart Co.Ltd (038460) - Total Assets
Latest total assets as of September 2025: ₩287.99 Billion KRW
Based on the latest financial reports, BioSmart Co.Ltd (038460) holds total assets worth ₩287.99 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioSmart Co.Ltd - Total Assets Trend (2010–2024)
This chart illustrates how BioSmart Co.Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioSmart Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
BioSmart Co.Ltd's total assets of ₩287.99 Billion consist of 50.9% current assets and 49.1% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩690.40 Million | 3.9% |
| Accounts Receivable | ₩44.82 Billion | 17.1% |
| Inventory | ₩50.45 Billion | 19.2% |
| Property, Plant & Equipment | ₩48.82 Billion | 18.6% |
| Intangible Assets | ₩4.15 Billion | 1.6% |
| Goodwill | ₩5.14 Billion | 2.0% |
Asset Composition Trend (2010–2024)
This chart illustrates how BioSmart Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioSmart Co.Ltd's current assets represent 50.9% of total assets in 2024, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 3.9% of total assets in 2024, down from 8.0% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 19.2% of total assets.
BioSmart Co.Ltd Competitors by Total Assets
Key competitors of BioSmart Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yujin Robot Co. Ltd
KQ:056080
|
Korea | ₩60.18 Billion |
|
SANGBO Corp
KQ:027580
|
Korea | ₩98.38 Billion |
|
S&K Polytec Co. Ltd
KQ:091340
|
Korea | ₩252.34 Billion |
|
Inzi Display Co.Ltd
KQ:037330
|
Korea | ₩543.17 Billion |
|
CoAsia Corporation
KQ:045970
|
Korea | ₩372.79 Billion |
|
e-LITECOM CO. Ltd
KQ:041520
|
Korea | ₩182.96 Billion |
|
Powerlogics Co. Ltd
KQ:047310
|
Korea | ₩371.76 Billion |
|
Phoenix Materials Co. Ltd
KQ:050090
|
Korea | ₩15.70 Billion |
BioSmart Co.Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - BioSmart Co.Ltd generates 1.84x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, BioSmart Co.Ltd generates $ 0.05 in net profit.
BioSmart Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.86 | 1.47 | 1.50 |
| Quick Ratio | 1.24 | 0.97 | 0.86 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩74.60 Billion | ₩ 44.84 Billion | ₩ 29.10 Billion |
BioSmart Co.Ltd - Advanced Valuation Insights
This section examines the relationship between BioSmart Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.91 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 1.1% |
| Total Assets | ₩262.84 Billion |
| Market Capitalization | $46.07 Million USD |
Valuation Analysis
Below Book Valuation: The market values BioSmart Co.Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: BioSmart Co.Ltd's assets grew by 1.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for BioSmart Co.Ltd (2010–2024)
The table below shows the annual total assets of BioSmart Co.Ltd from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩262.84 Billion | +1.07% |
| 2023-12-31 | ₩260.06 Billion | +9.65% |
| 2022-12-31 | ₩237.18 Billion | +5.02% |
| 2021-12-31 | ₩225.85 Billion | +34.25% |
| 2020-12-31 | ₩168.23 Billion | -8.34% |
| 2019-12-31 | ₩183.54 Billion | +29.82% |
| 2018-12-31 | ₩141.38 Billion | +25.41% |
| 2017-12-31 | ₩112.74 Billion | +0.51% |
| 2016-12-31 | ₩112.17 Billion | +50.40% |
| 2015-12-31 | ₩74.58 Billion | +10.06% |
| 2014-12-31 | ₩67.76 Billion | -6.05% |
| 2013-12-31 | ₩72.12 Billion | +4.49% |
| 2012-12-31 | ₩69.02 Billion | -0.02% |
| 2011-12-31 | ₩69.04 Billion | +52.05% |
| 2010-12-31 | ₩45.41 Billion | -- |